PI3K inhibitors curtail MYC-dependent mutant p53 gain-of-function in head and neck squamous cell carcinoma.

Posted on February 14, 2020

Ganci F, Pulito C, Valsoni S, Sacconi A, Turco C, Vahabi M, Manciocco V, Mazza EMC, Meens J, Karamboulas C, Nichols AC, Covello R, Pellini R, Spriano G, Sanguineti G, Muti P, Bicciato S, Ailles L, Strano S, Fontemaggi G, Blandino G.

Clin Cancer Res. 2020 Jan 22. pii: clincanres.2485.2019. doi: 10.1158/1078-0432.CCR-19-2485. [Epub ahead of print]PMID: 31969334

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY